Frost & Sullivan Release: SPECT/CT Rebuilds the North American Nuclear Medicine Equipment Market
2/25/2008 8:36:54 AM
PALO ALTO, Calif.--(BUSINESS WIRE)--The North American Nuclear Medicine Equipment Market expects to soon recover from the effects of the Deficit Reduction Act (DRA) of 2005. The single positron emission computed tomography/computed tomography (SPECT/CT) segment, and its ability to provide diagnostic CT, leads this charge and opens up numerous lucrative opportunities in niche markets such as neuroendocrine tumor imaging.
comments powered by